{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Keap1/Nrf2/ARE pathway", "NF-\u03ba B", "Nrf2", "SARS-CoV-2", "ozone therapy 1"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32384798", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "05", "Day": "06"}], "ELocationID": ["389", "10.3390/antiox9050389"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "9", "Issue": "5", "PubDate": {"Year": "2020", "Month": "May", "Day": "06"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.", "Abstract": {"AbstractText": ["(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-\u03ba B/Nrf2 pathways and IL-6/IL-1\u03b2 expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-\u03ba B/Nrf2 balance and IL-6 and IL-1\u03b2 expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific advisor, Freelance, 60126 Ancona, Italy."}], "LastName": "Mart\u00ednez-S\u00e1nchez", "ForeName": "Gregorio", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinica Fiorela Madrid, 28035 Madrid, Spain."}], "LastName": "Schwartz", "ForeName": "Adriana", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dama Salus Medical Center, 76125 Trani, Italy."}], "LastName": "Donna", "ForeName": "Vincenzo Di", "Initials": "VD"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105924", "PMC7127800", "32081636"]}, {"Citation": "World Health Organization  Director-General\u2019s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020.  [(accessed on 3 March 2020)]; Available online:  https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020."}, {"Citation": "Li X., Zai J., Zhao Q., Nie Q., Li Y., Foley B.T., Chaillon A. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J. Med. Virol. 2020;92:602\u2013611. doi: 10.1002/jmv.25731.", "ArticleIdList": ["10.1002/jmv.25731", "PMC7228310", "32104911"]}, {"Citation": "Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect. Genet. Evol. 2020;81:104260. doi: 10.1016/j.meegid.2020.104260.", "ArticleIdList": ["10.1016/j.meegid.2020.104260", "PMC7106203", "32092483"]}, {"Citation": "Habibzadeh P., Stoneman E.K. The Novel Coronavirus: A Bird\u2019s Eye View. Int. J. Occup. Environ. Med. 2020;11:65\u201371. doi: 10.15171/ijoem.2020.1921.", "ArticleIdList": ["10.15171/ijoem.2020.1921", "PMC7205509", "32020915"]}, {"Citation": "Xiong Y., Sun D., Liu Y., Fan Y., Zhao L., Li X., Zhu W. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Investig. Radiol. 2020;55 doi: 10.1097/RLI.0000000000000674.", "ArticleIdList": ["10.1097/RLI.0000000000000674", "PMC7147282", "32134800"]}, {"Citation": "WHO  Responding to Community Spread of COVID-19 Interim Guidance 7 March 2020.  [(accessed on 12 March 2020)]; Available online:  https://apps.who.int/iris/handle/10665/331421."}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001282.", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "World Health Organization  International Clinical Trials Registry Platform.  [(accessed on 7 March 2020)]; Available online:  http://apps.who.int/trialsearch/"}, {"Citation": "U.S. National Library of Medicine  Clinical Trials.gov.  [(accessed on 7 March 2020)]; Available online:  https://www.clinicaltrials.gov/"}, {"Citation": "Deng S.Q., Peng H.J. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J. Clin. Med. 2020;9:575. doi: 10.3390/jcm9020575.", "ArticleIdList": ["10.3390/jcm9020575", "PMC7074453", "32093211"]}, {"Citation": "Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J., Wang H., Shen H., Qiu L., Li Z., et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J. Pathol. 2004;203:622\u2013630. doi: 10.1002/path.1560.", "ArticleIdList": ["10.1002/path.1560", "PMC7167761", "15141376"]}, {"Citation": "Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev. Res. 2020 doi: 10.1002/ddr.21656.", "ArticleIdList": ["10.1002/ddr.21656", "PMC7228359", "32129518"]}, {"Citation": "Bocci V. Ozone. A New Medical Drug. 2nd ed. Springer; Dordrecht, The Netherlands: 2011."}, {"Citation": "Schwartz-Tapia A., Mart\u00ednez-S\u00e1nchez G., Sabah F., Alvarado-Gu\u00e9mez F., Bazzano-Mastrelli N., Bikina O., Borroto-Rodr\u00edgez V., Cakir R., Clavo B., Gonz\u00e1lez-S\u00e1nchez E., et al. Madrid Declaration on Ozone Therapy. ISCO3; Madrid, Spain: 2015. p. 50."}, {"Citation": "Leon O.S., Menendez S., Merino N., Castillo R., Sam S., Perez L., Cruz E., Bocci V. Ozone oxidative preconditioning: A protection against cellular damage by free radicals. Mediat. Inflamm. 1998;7:289\u2013294. doi: 10.1080/09629359890983.", "ArticleIdList": ["10.1080/09629359890983", "PMC1781855", "9792340"]}, {"Citation": "Pecorelli A., Bocci V., Acquaviva A., Belmonte G., Gardi C., Virgili F., Ciccoli L., Valacchi G. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol. Appl. Pharmacol. 2013;267:30\u201340. doi: 10.1016/j.taap.2012.12.001.", "ArticleIdList": ["10.1016/j.taap.2012.12.001", "23253326"]}, {"Citation": "Delgado-Roche L., Riera-Romo M., Mesta F., Hernandez-Matos Y., Barrios J.M., Martinez-Sanchez G., Al-Dalaien S.M. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur. J. Pharmacol. 2017;811:148\u2013154. doi: 10.1016/j.ejphar.2017.06.017.", "ArticleIdList": ["10.1016/j.ejphar.2017.06.017", "28623000"]}, {"Citation": "Galie M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Clavo B., Santana-Rodr\u00edguez N., Llontop P., Guti\u00e9rrez D., Su\u00e1rez G., L\u00f3pez L., Rovira G., Mart\u00ednez-S\u00e1nchez G., Gonz\u00e1lez E., Jorge I.J., et al. Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted? Evid.-Based Complement. Altern. Med. eCAM. 2018;2018:7931849. doi: 10.1155/2018/7931849.", "ArticleIdList": ["10.1155/2018/7931849", "PMC6151231", "30271455"]}, {"Citation": "Clavo B., Rodriguez-Esparragon F., Rodriguez-Abreu D., Martinez-Sanchez G., Llontop P., Aguiar-Bujanda D., Fernandez-Perez L., Santana-Rodriguez N. Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects. Antioxidants. 2019;8:588. doi: 10.3390/antiox8120588.", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Peirone C., Mestre V.F., Medeiros-Fonseca B., Colaco B., Pires M.J., Martins T., da Gil Costa R.M., Neuparth M.J., Medeiros R., Bastos M., et al. Ozone therapy prevents the onset of dysplasia in HPV16-transgenic mice-A pre-clinical efficacy and safety analysis. Biomed. Pharmacother. 2018;104:275\u2013279. doi: 10.1016/j.biopha.2018.05.018.", "ArticleIdList": ["10.1016/j.biopha.2018.05.018", "29775895"]}, {"Citation": "Mawsouf M., Tanbouli T., Viebahn-H\u00e4nsler R. Ozone Therapy in Patients with Viral Hepatitis C: Ten Years\u2019 Experience. Ozone Sci. Eng. 2012;34:451\u2013458. doi: 10.1080/01919512.2012.720161.", "ArticleIdList": ["10.1080/01919512.2012.720161"]}, {"Citation": "Murray B.K., Ohmine S., Tomer D.P., Jensen K.J., Johnson F.B., Kirsi J.J., Robison R.A., O\u2019Neill K.L. Virion disruption by ozone-mediated reactive oxygen species. J. Virol. Methods. 2008;153:74\u201377. doi: 10.1016/j.jviromet.2008.06.004.", "ArticleIdList": ["10.1016/j.jviromet.2008.06.004", "18598719"]}, {"Citation": "ISCO3  . ISCO3/LEG/00/10. ISCO3; Madrid, Spain: 2017.  [(accessed on 7 March 2020)]. Non-recommended routes of application in ozone therapy; p. 13. Available online:  www.isco3.org."}, {"Citation": "Burgassi S., Zanardi I., Travagli V., Montomoli E., Bocci V. How much ozone bactericidal activity is compromised by plasma components? J. Appl. Microbiol. 2009;106:1715\u20131721. doi: 10.1111/j.1365-2672.2008.04141.x.", "ArticleIdList": ["10.1111/j.1365-2672.2008.04141.x", "19226394"]}, {"Citation": "Bocci V., Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. Haematologica. 1990;75:510\u2013515.", "ArticleIdList": ["2129118"]}, {"Citation": "Martinez-Sanchez G. Mechanisms of action of O3. Genomic pathways. Ozone Ther. Glob. J. 2019;9:21\u201322."}, {"Citation": "Martinez-Sanchez G., Delgado-Roche L. Up-date on the mechanisms of action of ozone through the modification of cellular signaling pathways. Role of Nrf2 and NFkb. Rev. Esp. Ozonoterapia. 2017;7:17\u201318."}, {"Citation": "Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front. Chem. 2015;3:4. doi: 10.3389/fchem.2015.00004.", "ArticleIdList": ["10.3389/fchem.2015.00004", "PMC4313773", "25699252"]}, {"Citation": "Re L., Martinez-Sanchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M.A., Rothchild J., Rojas A. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 2014;742:158\u2013162. doi: 10.1016/j.ejphar.2014.08.029.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H., Wang H., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235\u2013249. doi: 10.1016/j.cell.2008.02.043.", "ArticleIdList": ["10.1016/j.cell.2008.02.043", "PMC7112336", "18423196"]}, {"Citation": "Rossmann A., Mandic R., Heinis J., Hoffken H., Kussner O., Kinscherf R., Weihe E., Bette M. Intraperitoneal oxidative stress in rabbits with papillomavirus-associated head and neck cancer induces tumoricidal immune response that is adoptively transferable. Clin. Cancer Res. 2014;20:4289\u20134301. doi: 10.1158/1078-0432.CCR-14-0677.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-0677", "24944316"]}, {"Citation": "Larini A., Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol. Vitr. 2005;19:55\u201361. doi: 10.1016/j.tiv.2004.06.007.", "ArticleIdList": ["10.1016/j.tiv.2004.06.007", "15582356"]}, {"Citation": "Ye Q., Wang B., Mao J. The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J. Infect. 2020 doi: 10.1016/j.jinf.2020.03.037.", "ArticleIdList": ["10.1016/j.jinf.2020.03.037", "PMC7194613", "32283152"]}, {"Citation": "Zhang C., Wu Z., Li J.W., Zhao H., Wang G.Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int. J. Antimicrob. Agents. 2020:105954. doi: 10.1016/j.ijantimicag.2020.105954.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105954", "PMC7118634", "32234467"]}, {"Citation": "Lintas G., Liboni W., Simonetti V., Franzini M., Valdenassi L., Vaiano F., Pandolfi S., Molinari F. Terzo Congresso del Gruppo Nazionale di Bioingegneria: 2012. Politecnico di Milano; Rome, Italy: 2012. Long-term cerebrovascular reactivity mediated by ozone autohemotherapy: A NIRS study."}, {"Citation": "Zaky S., Fouad E.A., Kotb H.I.M. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study) Br. J. Clin. Pharmacol. 2011;71:411\u2013415. doi: 10.1111/j.1365-2125.2010.03851.x.", "ArticleIdList": ["10.1111/j.1365-2125.2010.03851.x", "PMC3045550", "21284700"]}, {"Citation": "Clavo B., Perez J.L., Lopez L., Suarez G., Lloret M., Rodriguez V., Macias D., Santana M., Morera J., Fiuza D., et al. Effect of ozone therapy on muscle oxygenation. J. Altern. Complement. Med. 2003;9:251\u2013256. doi: 10.1089/10755530360623365.", "ArticleIdList": ["10.1089/10755530360623365", "12804078"]}, {"Citation": "Guan Y.J., Tang X.P., Yin C.B., Yi Z.Q. Study on the damage of liver in patients with SARS. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004;16:267\u2013270.", "ArticleIdList": ["15132787"]}, {"Citation": "Venkataraman T., Frieman M.B. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antivir. Res. 2017;143:142\u2013150. doi: 10.1016/j.antiviral.2017.03.022.", "ArticleIdList": ["10.1016/j.antiviral.2017.03.022", "PMC5507769", "28390872"]}, {"Citation": "Khan G. A novel coronavirus capable of lethal human infections: An emerging picture. Virol. J. 2013;10:66. doi: 10.1186/1743-422X-10-66.", "ArticleIdList": ["10.1186/1743-422X-10-66", "PMC3599982", "23445530"]}, {"Citation": "Simonetti V., Quagliariello V., Franzini M., Iaffaioli R.V., Maurea N., Valdenassi L. Ozone Exerts Cytoprotective and Anti-Inflammatory Effects in Cardiomyocytes and Skin Fibroblasts after Incubation with Doxorubicin. Evid. Based Complement. Altern. Med. 2019;2019:2169103. doi: 10.1155/2019/2169103.", "ArticleIdList": ["10.1155/2019/2169103", "PMC6885772", "31827546"]}, {"Citation": "Delgado-Roche L., Hernandez-Matos Y., Medina E.A., Morejon D.A., Gonzalez M.R., Martinez-Sanchez G. Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats. Sultan Qaboos Univ. Med. J. 2014;14:e342\u2013e348.", "ArticleIdList": ["PMC4117659", "25097769"]}, {"Citation": "Adali Y., Eroglu H.A., Makav M., Guvendi G.F. Efficacy of Ozone and Selenium Therapy for Alcoholic Liver Injury: An Experimental Model. In Vivo. 2019;33:763\u2013769. doi: 10.21873/invivo.11537.", "ArticleIdList": ["10.21873/invivo.11537", "PMC6559901", "31028195"]}, {"Citation": "Tezcan A.H., Ozturk O., Ustebay S., Adali Y., Yagmurdur H. The beneficial effects of ozone therapy in acetaminophen-induced hepatotoxicity in mice. Pharmacol. Rep. 2018;70:340\u2013345. doi: 10.1016/j.pharep.2017.11.003.", "ArticleIdList": ["10.1016/j.pharep.2017.11.003", "29477043"]}, {"Citation": "Kaldirim U., Uysal B., Yuksel R., Macit E., Eyi Y.E., Toygar M., Tuncer S.K., Ardic S., Arziman I., Aydin I., et al. Ozone therapy ameliorates paraquat-induced lung injury in rats. Exp. Biol. Med. 2014;239:1699\u20131704. doi: 10.1177/1535370214543060.", "ArticleIdList": ["10.1177/1535370214543060", "25030482"]}, {"Citation": "Wang L., Chen H., Liu X.H., Chen Z.Y., Weng X.D., Qiu T., Liu L., Zhu H.C. Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats. Exp. Ther. Med. 2014;8:1764\u20131768. doi: 10.3892/etm.2014.2004.", "ArticleIdList": ["10.3892/etm.2014.2004", "PMC4218702", "25371729"]}, {"Citation": "Bocci V., Zanardi I., Travagli V. Ozonation of human HIV-infected plasmas for producing a global vaccine: How HIV-patients may help fight the HIV pandemia. Virulence. 2010;1:215\u2013217. doi: 10.4161/viru.1.3.11830.", "ArticleIdList": ["10.4161/viru.1.3.11830", "21178445"]}, {"Citation": "Bocci V., Travagli V., Zanardi I. The failure of HIV vaccines: A new autovaccine may overcome some problems. Med. Hypotheses. 2009;72:662\u2013664. doi: 10.1016/j.mehy.2008.12.034.", "ArticleIdList": ["10.1016/j.mehy.2008.12.034", "19223126"]}, {"Citation": "Peretiagyn S.P., Struchkov \u0410.\u0410., Peretiagyn N.C., \u041aulechina N.\u0412. \u041c\u041a\u0418 \u0410 61 \u041a 33/40\u0411\u044e\u043b. Volume 2004126456/15 Novgorod RSoOTN; Nizhny Novgorod, Russia: 2006. Ozonization Method of Saline Solution."}, {"Citation": "Maslennikov O.V., Kontorshikova C.N., Gribkova I.A. Ozone Therapy in Practice. Health Manual, Ministry Health Service of the Russian Federation the State Medical Academy of Nizhny Novgorod, Russia.  [(accessed on 7 March 2020)];2008  Available online:  http://www.absoluteozone.com/assets/ozone_therapy_in_practice.pdf."}, {"Citation": "Boyarinov G.A., Sokolov V.V. Russian Scientific Congress of Ozone Therapy. Volume 1. Russian Society of Ozone Therapy; Nizhny Novgorod, Russia: 1999. Ozonized cardiopulmonary bypass (experimental justification and clinical results) p. 82."}, {"Citation": "Korolev B.A., Boiarinov G.A., Monakhov A.N., Shvets N.A., Peretiagin S.P. Metabolism and ultrastructure of the myocardium in protection of the heart against ischemia using an ozonized cardioplegic solution. Grud. Khirurgiia. 1983;6:27\u201331.", "ArticleIdList": ["6654158"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 2009;29:646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Bocci V.A., Zanardi I., Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Viebahn-Hansler R., Leon Fernandez O.S., Fahmy Z. Ozone in Medicine: The Low-Dose Ozone Concept\u2014Guidelines and Treatment Strategies. Ozone-Sci. Eng. 2012;34:408\u2013424. doi: 10.1080/01919512.2012.717847.", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Milkovic L., Cipak Gasparovic A., Zarkovic N. Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor. Free Radic. Res. 2015;49:850\u2013860. doi: 10.3109/10715762.2014.999056.", "ArticleIdList": ["10.3109/10715762.2014.999056", "25532703"]}, {"Citation": "Wang L., Chen Z., Liu Y., Du Y., Liu X. Ozone oxidative postconditioning inhibits oxidative stress and apoptosis in renal ischemia and reperfusion injury through inhibition of MAPK signaling pathway. Drug Des. Dev. Ther. 2018;12:1293\u20131301. doi: 10.2147/DDDT.S164927.", "ArticleIdList": ["10.2147/DDDT.S164927", "PMC5968808", "29861623"]}, {"Citation": "Galie M., Costanzo M., Nodari A., Boschi F., Calderan L., Mannucci S., Covi V., Tabaracci G., Malatesta M. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic. Biol. Med. 2018;124:114\u2013121. doi: 10.1016/j.freeradbiomed.2018.05.093.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.05.093", "29864481"]}, {"Citation": "Siniscalco D., Trotta M.C., Brigida A.L., Maisto R., Luongo M., Ferraraccio F., D\u2019Amico M., Di Filippo C. Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin. Biology. 2018;7:10. doi: 10.3390/biology7010010.", "ArticleIdList": ["10.3390/biology7010010", "PMC5872036", "29324687"]}, {"Citation": "Breitzig M., Bhimineni C., Lockey R., Kolliputi N. 4-Hydroxy-2-nonenal: A critical target in oxidative stress? Am. J. Physiol. Cell Physiol. 2016;311:C537\u2013C543. doi: 10.1152/ajpcell.00101.2016.", "ArticleIdList": ["10.1152/ajpcell.00101.2016", "PMC5129750", "27385721"]}, {"Citation": "Kobayashi E.H., Suzuki T., Funayama R., Nagashima T., Hayashi M., Sekine H., Tanaka N., Moriguchi T., Motohashi H., Nakayama K., et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 2016;7:11624. doi: 10.1038/ncomms11624.", "ArticleIdList": ["10.1038/ncomms11624", "PMC4879264", "27211851"]}, {"Citation": "Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:585\u2013597. doi: 10.1016/j.bbadis.2016.11.005.", "ArticleIdList": ["10.1016/j.bbadis.2016.11.005", "27825853"]}, {"Citation": "Mohan S., Gupta D. Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation. Biomed. Pharmacother. 2018;108:1866\u20131878. doi: 10.1016/j.biopha.2018.10.019.", "ArticleIdList": ["10.1016/j.biopha.2018.10.019", "30372892"]}, {"Citation": "Wardyn J.D., Ponsford A.H., Sanderson C.M. Dissecting molecular cross-talk between Nrf2 and NF-kappaB response pathways. Biochem. Soc. Trans. 2015;43:621\u2013626. doi: 10.1042/BST20150014.", "ArticleIdList": ["10.1042/BST20150014", "PMC4613495", "26551702"]}, {"Citation": "Ganesh Yerra V., Negi G., Sharma S.S., Kumar A. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kappaB pathways in diabetic neuropathy. Redox Biol. 2013;1:394\u2013397. doi: 10.1016/j.redox.2013.07.005.", "ArticleIdList": ["10.1016/j.redox.2013.07.005", "PMC3757712", "24024177"]}, {"Citation": "Dai J.P., Wang Q.W., Su Y., Gu L.M., Zhao Y., Chen X.X., Chen C., Li W.Z., Wang G.F., Li K.S. Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways. Molecules. 2017;22:1754. doi: 10.3390/molecules22101754.", "ArticleIdList": ["10.3390/molecules22101754", "PMC6151665", "29057806"]}, {"Citation": "Hu B., Wei H., Song Y., Chen M., Fan Z., Qiu R., Zhu W., Xu W., Wang F. NF-kappaB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection. J. Virol. 2020 doi: 10.1128/JVI.00016-20.", "ArticleIdList": ["10.1128/JVI.00016-20", "PMC7199420", "32161178"]}, {"Citation": "Conti P., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Frydas I., Kritas S.K. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: Anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34 doi: 10.23812/conti-e.", "ArticleIdList": ["10.23812/conti-e", "32171193"]}, {"Citation": "Zalinger Z.B., Elliott R., Weiss S.R. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus. J. Neurovirol. 2017;23:845\u2013854. doi: 10.1007/s13365-017-0574-4.", "ArticleIdList": ["10.1007/s13365-017-0574-4", "PMC5726909", "28895072"]}, {"Citation": "Yang M.L., Wang C.T., Yang S.J., Leu C.H., Chen S.H., Wu C.L., Shiau A.L. IL-6 ameliorates acute lung injury in influenza virus infection. Sci. Rep. 2017;7:43829. doi: 10.1038/srep43829.", "ArticleIdList": ["10.1038/srep43829", "PMC5338329", "28262742"]}, {"Citation": "Bette M., Nusing R.M., Mutters R., Zamora Z.B., Menendez S., Schulz S. Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum. Shock. 2006;25:23\u201329. doi: 10.1097/01.shk.0000187983.56030.dd.", "ArticleIdList": ["10.1097/01.shk.0000187983.56030.dd", "16369182"]}, {"Citation": "Wang J., Wu M., Lin X., Li Y., Fu Z. Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-\u03baB/p65 Signaling in Chronic Radiculitis Rats. Pain Res. Manag. 2018;2018:5192814. doi: 10.1155/2018/5192814.", "ArticleIdList": ["10.1155/2018/5192814", "PMC6311849", "30651902"]}, {"Citation": "Noguchi F., Kitamura C., Nagayoshi M., Chen K.K., Terashita M., Nishihara T. Ozonated water improves lipopolysaccharide-induced responses of an odontoblast-like cell line. J. Endod. 2009;35:668\u2013672. doi: 10.1016/j.joen.2009.01.016.", "ArticleIdList": ["10.1016/j.joen.2009.01.016", "19410080"]}, {"Citation": "Wang Z., Zhang A., Meng W., Wang T., Li D., Liu Z., Liu H. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 2018;835:82\u201393. doi: 10.1016/j.ejphar.2018.07.059.", "ArticleIdList": ["10.1016/j.ejphar.2018.07.059", "30075224"]}, {"Citation": "Re L., Malcangi G., Mart\u00ednez-S\u00e1nchez G. Medical ozone is now ready for a scientific challenge: Current status and future perspectives. J. Exp. Integr. Med. 2012;2:193\u2013196. doi: 10.5455/jeim.070612.ir.012.", "ArticleIdList": ["10.5455/jeim.070612.ir.012"]}, {"Citation": "Di Mauro R., Cantarella G., Bernardini R., Di Rosa M., Barbagallo I., Distefano A., Longhitano L., Vicario N., Nicolosi D., Lazzarino G., et al. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int. J. Mol. Sci. 2019;20:634. doi: 10.3390/ijms20030634.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "3", "Day": "29"}, {"Year": "2020", "Month": "5", "Day": "1"}, {"Year": "2020", "Month": "5", "Day": "4"}, {"Year": "2020", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "5", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["32384798", "PMC7278582", "10.3390/antiox9050389", "antiox9050389"]}}], "PubmedBookArticle": []}